401 related articles for article (PubMed ID: 36644710)
1. Fractalkine/CX3CR1-Dependent Modulation of Synaptic and Network Plasticity in Health and Disease.
Camacho-Hernández NP; Peña-Ortega F
Neural Plast; 2023; 2023():4637073. PubMed ID: 36644710
[TBL] [Abstract][Full Text] [Related]
2. Fractalkine/CX3CR1 is involved in the cross-talk between neuron and glia in neurological diseases.
Luo P; Chu SF; Zhang Z; Xia CY; Chen NH
Brain Res Bull; 2019 Mar; 146():12-21. PubMed ID: 30496784
[TBL] [Abstract][Full Text] [Related]
3. Microglia Mediate HIV-1 gp120-Induced Synaptic Degeneration in Spinal Pain Neural Circuits.
Ru W; Liu X; Bae C; Shi Y; Walikonis R; Mo Chung J; Tang SJ
J Neurosci; 2019 Oct; 39(42):8408-8421. PubMed ID: 31471472
[TBL] [Abstract][Full Text] [Related]
4. FKN/CX3CR1 axis facilitates migraine-Like behaviour by activating thalamic-cortical network microglia in status epilepticus model rats.
Zhou Y; Zhang L; Hao Y; Yang L; Fan S; Xiao Z
J Headache Pain; 2022 Apr; 23(1):42. PubMed ID: 35382731
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotective Effect of Fractalkine on Radiation-induced Brain Injury Through Promoting the M2 Polarization of Microglia.
Wang J; Pan H; Lin Z; Xiong C; Wei C; Li H; Tong F; Dong X
Mol Neurobiol; 2021 Mar; 58(3):1074-1087. PubMed ID: 33089423
[TBL] [Abstract][Full Text] [Related]
6. Fractalkine Enhances Hematoma Resolution and Improves Neurological Function via CX3CR1/AMPK/PPARγ Pathway After GMH.
Chen X; He X; Xu F; Xu N; Sharifi NH; Zhang P; Flores JJ; Wu L; He Q; Kanamaru H; Zhu S; Dong S; Han M; Yuan Y; Huang L; Miao L; Zhang JH; Zhou Y; Tang J
Stroke; 2023 Sep; 54(9):2420-2433. PubMed ID: 37465997
[TBL] [Abstract][Full Text] [Related]
7. Modulation of inflammatory responses by fractalkine signaling in microglia.
Inoue K; Morimoto H; Ohgidani M; Ueki T
PLoS One; 2021; 16(5):e0252118. PubMed ID: 34019594
[TBL] [Abstract][Full Text] [Related]
8. The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders.
Pawelec P; Ziemka-Nalecz M; Sypecka J; Zalewska T
Cells; 2020 Oct; 9(10):. PubMed ID: 33065974
[TBL] [Abstract][Full Text] [Related]
9. Microglia and Aging: The Role of the TREM2-DAP12 and CX3CL1-CX3CR1 Axes.
Mecca C; Giambanco I; Donato R; Arcuri C
Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29361745
[TBL] [Abstract][Full Text] [Related]
10. Neuron-glia crosstalk in health and disease: fractalkine and CX3CR1 take centre stage.
Sheridan GK; Murphy KJ
Open Biol; 2013 Dec; 3(12):130181. PubMed ID: 24352739
[TBL] [Abstract][Full Text] [Related]
11. Up-regulated fractalkine (FKN) and its receptor CX3CR1 are involved in fructose-induced neuroinflammation: Suppression by curcumin.
Xu MX; Yu R; Shao LF; Zhang YX; Ge CX; Liu XM; Wu WY; Li JM; Kong LD
Brain Behav Immun; 2016 Nov; 58():69-81. PubMed ID: 26765996
[TBL] [Abstract][Full Text] [Related]
12. Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice.
Staniland AA; Clark AK; Wodarski R; Sasso O; Maione F; D'Acquisto F; Malcangio M
J Neurochem; 2010 Aug; 114(4):1143-57. PubMed ID: 20524966
[TBL] [Abstract][Full Text] [Related]
13. CX3CL1 Pathway as a Molecular Target for Treatment Strategies in Alzheimer's Disease.
Bivona G; Iemmolo M; Ghersi G
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175935
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents.
Poniatowski ŁA; Wojdasiewicz P; Krawczyk M; Szukiewicz D; Gasik R; Kubaszewski Ł; Kurkowska-Jastrzębska I
Mol Neurobiol; 2017 Apr; 54(3):2167-2188. PubMed ID: 26927660
[TBL] [Abstract][Full Text] [Related]
15. Abnormal innate and learned behavior induced by neuron-microglia miscommunication is related to CA3 reconfiguration.
Méndez-Salcido FA; Torres-Flores MI; Ordaz B; Peña-Ortega F
Glia; 2022 Sep; 70(9):1630-1651. PubMed ID: 35535571
[TBL] [Abstract][Full Text] [Related]
16. Effects of CX3CR1 and Fractalkine Chemokines in Amyloid Beta Clearance and p-Tau Accumulation in Alzheimer's Disease (AD) Rodent Models: Is Fractalkine a Systemic Biomarker for AD?
Merino JJ; Muñetón-Gómez V; Alvárez MI; Toledano-Díaz A
Curr Alzheimer Res; 2016; 13(4):403-12. PubMed ID: 26567742
[TBL] [Abstract][Full Text] [Related]
17. Fractalkine/CX3CR1 signalling in chronic pain and inflammation.
Clark AK; Staniland AA; Malcangio M
Curr Pharm Biotechnol; 2011 Oct; 12(10):1707-14. PubMed ID: 21466443
[TBL] [Abstract][Full Text] [Related]
18. The microglial fractalkine receptor is not required for activity-dependent plasticity in the mouse visual system.
Lowery RL; Tremblay ME; Hopkins BE; Majewska AK
Glia; 2017 Nov; 65(11):1744-1761. PubMed ID: 28836393
[TBL] [Abstract][Full Text] [Related]
19. CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis.
Szukiewicz D
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731899
[TBL] [Abstract][Full Text] [Related]
20. Enhanced fear and altered neuronal activation in forebrain limbic regions of CX3CR1-deficient mice.
Schubert I; Ahlbrand R; Winter A; Vollmer L; Lewkowich I; Sah R
Brain Behav Immun; 2018 Feb; 68():34-43. PubMed ID: 28943292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
